Biosite BNP (B-type natriuretic peptide) HF (heart failure) test:
This article was originally published in Clinica
Executive Summary
Expanding the indications for its heart failure (HF) blood test, Biosite has gained US FDA 510(k) clearance to use its Triage BNP (B-type natriuretic peptide) test as a means of helping physicians assess the risk of mortality or re-hospitalisation in patients with the condition. The San Diego, California firm has already received US clearance to use the test to help diagnose HF, assess disease severity and for risk stratification of patients with acute coronary syndromes.